688599:SSETrina Solar Ltd Class A Analysis
Data as of 2026-06-02 - not real-time
CN¥14.79
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Trina Solar is trading at CNY 14.79, barely above the computed support level of CNY 14.43 and well below its 20‑day SMA of 16.97, indicating a price that is currently under pressure. The RSI of 29 signals oversold conditions, while the MACD line sits beneath the signal line, reinforcing a short‑term bearish bias. Volume is on a decreasing trend despite a still‑high average, and the 30‑day volatility of nearly 39% suggests price swings could be pronounced. However, the stock’s beta of 0.21 points to low systematic risk relative to the broader market. On the fundamentals side, revenue grew 17.4% year‑over‑year, yet gross margin is only 3.9% and operating margin is negative, resulting in a trailing EPS of –2.75. The balance sheet is heavily leveraged with a debt‑to‑equity ratio of 166%, and ROE is –21%, underscoring profitability challenges. Despite these headwinds, the DCF‑derived fair value of roughly CNY 66.7 implies the market may be pricing in a substantial discount, while the forward PE of 123 vastly exceeds the industry average of 43. No dividend is paid, eliminating income‑yield considerations. Overall, the stock sits at a crossroads between technical oversold signals and deep valuation disparity, but its financial fragility and high leverage keep the upside speculative.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 5/10
Key Factors
- RSI in oversold territory
- Bearish MACD histogram
- Proximity to technical support
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Revenue growth offset by negative margins
- High debt burden limiting flexibility
- Significant valuation gap to DCF fair value
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Long‑term renewable energy demand tailwinds
- DCF fair value suggests large upside potential
- Strategic moves into energy storage and micro‑grid solutions
Key Metrics & Analysis
Financial Health
Revenue Growth17.40%
Profit Margin-8.63%
P/E Ratio123.3
ROE-21.39%
ROA-2.62%
Debt/Equity166.08
P/B Ratio1.6
Op. Cash FlowCN¥11.8B
Free Cash FlowCN¥6.5B
Industry P/E42.9
Technical Analysis
TrendNeutral
RSI29.2
SupportCN¥14.43
ResistanceCN¥18.78
MA 20CN¥16.97
MA 50CN¥16.89
MA 200CN¥17.80
MACDBearish
VolumeDecreasing
Fear & Greed Index92.64
Valuation
Fair ValueCN¥66.66
GradeUndervalued
TypeBlend
Risk Assessment
Beta0.21
Volatility38.84%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.